首页|期刊导航|汕头大学医学院学报|基于免疫球蛋白G N-糖链特征的结直肠腺瘤诊断模型构建与验证

基于免疫球蛋白G N-糖链特征的结直肠腺瘤诊断模型构建与验证OA

Construction and validation of a diagnostic model for colorectal adenoma based on immunoglobulin G N-glycan features

中文摘要英文摘要

目的:探讨免疫球蛋白G(IgG)N-糖链特征作为生物标志物在结直肠腺瘤(CRA)诊断中的潜在应用价值.方法:采用病例对照设计,于2021年3-9月纳入汕头大学医学院第二附属医院经结肠镜确诊的CRA患者90例及健康对照90例.采用亲水相互作用超高效液相色谱法检测血浆IgG N-糖链的相对丰度.通过LASSO回归筛选特征性糖链,并利用多因素logistic回归筛选独立关联因素并构建列线图诊断模型.采用受试者工作特征的曲线下面积(AUC)和校准曲线评估模型的区分度与校准度,Bootstrap法(1 000次重抽样)验证模型稳定性.结果:在22种直接检测的IgG N-糖链中,12种在两组间存在差异(经Benjamini-Hochberg法校正,P<0.05).LASSO筛选出6种糖链,多因素分析确认GP2(OR=19.00,95%CI:3.32~162.74)、GP10(OR=2.24,95%CI:1.18~4.59)、GP11(OR=2.33×10-3,95%CI:1.10×10-4~2.37×10-2)、GP19(OR=3.79,95%CI:1.75~9.08)为CRA的独立关联因素(均P<0.05).基于上述4因素构建的诊断模型区分效能良好(AUC=0.952,95%CI:0.923~0.980),Bootstrap验证平均AUC为0.954(95%CI:0.919~0.981),校准曲线显示预测概率与实际观测一致性较好(Brier=0.088).结论:本研究初步证实IgG N-糖链特征对CRA具有诊断区分潜力.然而,受回顾性设计、单中心小样本等限制,该模型的泛化能力及临床适用性需经多中心前瞻性研究进一步验证.

Objective:To explore the potential application value of immunoglobulin G(IgG)N-glycan features as biomarkers for the diagnosis of colorectal adenoma(CRA).Methods:A case-control study was conducted,enrolling 90 CRA patients confirmed by colonoscopy and 90 healthy controls from the Second Affiliated Hospital of Shantou University Medical College between March and September 2021.The relative abundance of plasma IgG N-glycans was detected using hydrophilic interaction ultra-performance liquid chromatography(HILIC-UPLC).Characteristic glycans were screened by LASSO regression,and independent associated factors were identified by multivariate logistic regression to construct a nomogram diagnostic model.The discriminative ability and calibration of the model were evaluated using the area under the receiver operating characteristic(ROC)curve(AUC)and calibration curves,respectively.Model stability was validated by the Bootstrap method(1 000 resamples).Results:Among the 22 directly detected IgG N-glycans,12 showed differential abundance between the two groups(adjusted P<0.05 by the Benjamini-Hochberg method).LASSO regression screened six glycans,and multivariate analysis confirmed that GP2(OR=19.00,95%CI:3.32-162.74),GP10(OR=2.24,95%CI:1.18-4.59),GP11(OR=2.33×10-3,95%CI:1.10×10-4-2.37×10-2),and GP19(OR=3.79,95%CI:1.75-9.08)were independently associated with CRA(all P<0.05).The diagnostic model constructed based on these four factors demonstrated good discriminative performance(AUC=0.952,95%CI:0.923-0.980).The average AUC from Bootstrap validation was 0.954(95%CI:0.919-0.981).The calibration curve indicated good consistency between predicted probabilities and actual observations(Brier score=0.088).Conclusion:This study preliminarily confirms that IgG N-glycan features have potential for discriminating CRA.However,due to limitations such as the retrospective design and single-center small sample size,the generalizability and clinical applicability of this diagnostic model require further validation through multicenter prospective studies.

许丽丽;郭国湖;陈晓东;许锐锐

汕头大学医学院第二附属医院,广东 汕头 515041汕头大学医学院第二附属医院,广东 汕头 515041汕头大学医学院第二附属医院,广东 汕头 515041汕头大学医学院第二附属医院,广东 汕头 515041||伊迪斯科文大学医学与健康科学学院,澳大利亚 珀斯 6027||化学与精细化工广东省实验室,广东 汕头 515041

医药卫生

IgG N-糖基化结直肠腺瘤诊断模型列线图生物标志物

IgG N-glycosylationcolorectal adenomadiagnostic modelnomogrambiomarker

《汕头大学医学院学报》 2026 (1)

31-37,7

汕头市医疗卫生科技计划(汕府科[2022]81号-85)

10.13401/j.cnki.jsumc.2026.01.006

评论